-
Jubilant Life Sciences announces generic Aldacone, Namenda
UTTAR PRADESH, India — Jubilant Life Sciences, an integrated pharmaceuticals and life sciences company, last week announced that it received approval from the Food and Drug Administration for spironolactone tablets, 25 mg, 50 mg and 100 mg, which is the generic version of Aldactone. The drug is used to treat fluid retention caused by congestive heart failure and cirrhosis of the liver.
The market size for spironolactone tablets is $87 million per annum, according to IMS data. The company said it expects to launch the product in first quarter 2015.
-
Target names new information officer
MINNEAPOLIS — Effective May 5, Bob DeRodes will lead Target’s information technology transformation as EVP and chief information officer, as the retailer continues to recover from the data breach late last year.
Target also provided details on additional security enhancements it has made following that breach — which reportedly resulted in the theft of 40 million credit and debit card records and 70 million other records of customer details — and shared plans to incorporate MasterCard chip-and-PIN technology across its REDcard portfolio.